Search
-
Keeping Research Close to Northern Nevada
Clinical research provides agency for our patients navigating a scary diagnosis, and the field has never been stronger in northern Nevada. This strength is thanks in part to the Affiliate Clinical Research Office (ACRO) formed by the 2021 affiliation between Renown Health and the University of Nevada, Reno School of Medicine. Since its creation, the ACRO team has been busy ensuring that community members have access to the latest care options and exceptional experiences as participants in both research and their healthcare. Here are just a few things that set this office apart from the rest. 1. A focus on engagement In 2022, the ARCO team focused on promoting a research culture with patients, clinicians, residents and students by intentionally engaging with healthcare providers, department administrators, internal research team members and leadership. They educated the community with learning materials that emphasized the importance of doing research. This team also worked with front-line staff to raise awareness and excitement about the clinical research options available for Renown Health patients. 2. Meaningful partnerships The most impactful partnership to date is between Renown Health and UNR Med. By identifying opportunities and leveraging resources across institutions, we have maximized our impact and built a solid and sustainable foundation. This gives the people of northern Nevada greater access to new interventions or novel treatments. This team is also investing in the community and national partnerships to provide training opportunities for our research staff and learning opportunities for our medical students. 3. Novel treatments across many disease areas Our research study offerings must reflect the healthcare needs of our community and the expertise of practicing clinicians. The department has over 80 active studies in neurology, pulmonology, oncology, cardiology, pediatrics and disease prevention. The ARCRO team strives to expand care opportunities to allow our community members to stay close to home when seeking care. This year, they will continue exploring our community's unmet healthcare needs by bringing new treatment options to the greater Reno area.
-
Getting to the HEART of Research
In February, we think about hearts not just in honor of Valentine’s Day but because it is American Heart Association Month. This is a great reminder to focus on our personal cardiovascular health. Renown Health helps patients think about their heart health with our world-class providers and cutting-edge treatments through our Cardiovascular Clinical Trials. “Research serves a vital role in the future care of cardiovascular diseases. Being involved in research will help our medical community to further discover new treatment plans in our quest for life preservation and extension,” Dr. Thomas To, Cardiologist and Researcher at Renown Health. For example, let’s talk about atherosclerosis. When our hearts are healthy, they are a strong muscle that pumps our oxygen-rich blood through our coronary arteries. Over time, cholesterol and fats can build up in our arteries. This is a condition known as atherosclerosis. This type of plaque buildup in the arteries can lead to a heart attack or stroke if not properly managed. If you are experiencing chest pain or discomfort, shortness of breath or pain in areas of the upper body, these can be the warning signs of a heart attack, and you should call 911. One contributing factor to atherosclerosis is elevated lipoprotein(a) levels and the accumulation of cholesterol in the arteries, which increases the likelihood of a heart attack or stroke. Lipoprotein(a) is tested separately from the standard panel that is completed for cholesterol management, and while your total cholesterol levels may be in a healthy range, lipoprotein(a) levels can still be elevated. "Increasingly we are realizing that lipoprotein(a) levels can be used as an important assessment in more carefully delineating an individual's risk of future cardiovascular events and treatment targets" said Dr. Michael Bloch, Lipid Specialist and Researcher at Renown Institute for Heart and Vascular Health. While it is clear that elevated lipoprotein(a) contributes to atherosclerosis, there are currently no approved medications for reducing cardiovascular disease risk through reducing lipoprotein(a) levels. This is why Renown Health’s Research Office is proud to offer a phase III clinical trial, called the OCEAN(a) study, to our patients with elevated lipoprotein(a) levels as a care option for management of their heart disease risk. Our teams of expert providers and researchers are here to support you on your healthcare journey. “I am thrilled to be able to be part of this study and bring opportunities like this to our patients. The highlight of my day is getting to hear life stories from my patients during our study visits,” Lisa Preciado, Primary Clinical Research Coordinator for the OCEAN(a) study said. Join us in raising awareness around American Heart Month by talking to your provider about lipoprotein(a) at your next appointment. At Renown Health, our goal is to make it easy for patients to access clinical research as a care opportunity where patients can access a variety of standard care treatment options for their health condition or choose to participate in a clinical trial. For more information about clinical trial opportunities available to you or to ask any questions, contact the Renown Research Office at Renown-CRD@renown.org or 775-982-3646.
-
Ovarian Cancer Survivor Shares Decision to Try Clinical Trial
While there used to be three basic treatment options for cancer -- surgery, radiation and chemotherapy, or a combination of the three -- there's a fourth option: clinical trials. Here, a Renown patient shares her successful battle with ovarian cancer, aided by a clinical trial. Shari Flamm's battle with ovarian cancer began in 2011. She was experiencing prolonged bleeding, irregular thyroid levels and anemia and was scheduled to undergo a hysterectomy. Before the surgery, her gynecologist ran routine tests to check for cancer as a precautionary measure. All tests were negative for cancer, expect her CA 125 test. A CA 125 test measures the amount of the protein CA 125 (cancer antigen 125) in the blood. In some cases, a CA 125 test may be used to look for early signs of ovarian cancer in women with a very high risk of the disease. In most laboratories, the normal level is 0 to 35 units/ml. Flamm's CA 125 level was 121. As Flamm can attest, early diagnosis played a key role in her battle with ovarian cancer. September is Gynecologic Cancer and Ovarian Cancer Awareness Month – an important time to learn the signs, symptoms and risk factors of this type of cancer so your doctor can diagnosis the disease as early as possible. Ovarian Cancer: Round One Despite the elevated CA 125 results, her doctor recommended they move forward with the hysterectomy. But when surgery began, doctors discovered a mass. She had stage 4 cancer. The procedure was halted, the mass was biopsied and she was immediately seen by Dr. Peter Lim of the The Center of Hope. Following diagnosis, Flamm underwent surgery with Dr. Lim to remove the cancer, which had spread to part of diaphragm, spleen, colon and other organs. Three months after surgery, Flamm had recovered enough to start six rounds of chemotherapy in her hometown of Carson City. She continued working at a doctor's office during her treatment, and was grateful for Dr. Lim’s ability to co-manage her care so she could stay close to work and family. “To me, chemo was the scariest part because I didn’t like feeling sick,” Flamm says. Thankfully, her body responded well to the treatments and she was back to the things she loved. “I stated working out at the gym, even if it was only for 10 minutes,” she says. She also stayed positive by spending time with her grandchildren, attending a San Jose Sharks hockey game, going for walks and enjoying concerts. Ovarian Cancer: Round Two In November 2014, Flamm had a cancer check-up. That’s when doctors discovered three cancerous tumors. For this round, Flamm choose another treatment option -- clinical trials at Renown Institute for Cancer. Clinical trials are the studies that test whether drugs work, and inform doctors' decisions about how to treat their patients. Flamm participated in a clinical trial that featured oral-targeted therapy stronger than IV chemotherapy. The hope was for the drug to shrink her tumors, however the result was stabilization -- meaning the lumps weren’t growing or spreading. The best part of the clinical trial, Flamm says, was the constant monitoring. Between the CT scans every six weeks, a heart scan every three months and monthly doctor visits, she was confident that if the cancer started growing or spreading, her healthcare team would catch it right away. For Flamm, the benefits of the clinical trial included less hair loss, less fatigue and more time to focus on what’s important in her life -- her family. “I decided I wasn’t going to be that sick grandma on the couch with cancer,” Flamm says. After taking the oral medication for one year, Flamm developed a rash and discontinued treatment due to discomfort. Clinical Trials, Setbacks and Survival In June 2016, two of the three tumors began to grow and had to be surgically removed. Despite the setback, Flamm was determined to maintain a positive outlook. "You have to stay positive because cancer feeds off anger, depression and stress," Flamm says. Flamm was released to go home with clear margins, meaning the tumors were removed and are surrounded by a rim of normal tissue that does not have cancerous cells. Flamm says her outlook on life has changed drastically since her first cancer diagnosis. “Your whole mentality changes when cancer disturbs your life," Flann says. "The things that weren’t important, are now ever so important. I’m a lot calmer now,” Flamm says.
Read More About Ovarian Cancer Survivor Shares Decision to Try Clinical Trial
-
What Does It Mean to Participate in a Clinical Trial?
Participating in a clinical trial is voluntary and a personal choice. Clinical trials are research studies that involve people and are an important part of patient care. What is a clinical trial? Clinical trials are research studies that involve people, and they are an important part of patient care. There are several different types of clinical trials; some are designed to understand trends in a disease or identify better ways to diagnose a condition, while others determine if a new treatment is safe and works when treating, improving or preventing a health condition. There are over 400,000 clinical trials currently being conducted in the United States, and even more across the world. This includes health conditions such as heart failure, cancer, Parkinson’s Disease, respiratory conditions like COPD, common infections, cystic fibrosis, and many more. Clinical trials lead the healthcare industry to new discoveries that contribute to reliable and exact care, improving healthcare quality and saving lives. Clinical trials are conducted by a team of researchers, including doctors, pharmacists and clinical research coordinators. These research teams are highly skilled in their specialty areas, often providing traditional patient care and seeing research patients in the same day. These teams are responsible for making sure the clinical trial is completed correctly, and their patients are their top priority. Why should I consider participating in a clinical trial? Participating in a clinical trial is voluntary and a personal choice. There are many reasons why patients decide to get involved in clinical research. While many clinical trials are designed for patients who have a certain health condition, many studies also ask healthy volunteers to contribute in order to compare health outcomes. Clinical trials are also for patients at all different stages of their diagnosis. Depending on the specific study, the patient may receive access to a new cutting-edge treatment before it is widely available. When patients join a clinical trial, the research team becomes a health partner dedicated to their health and well-being. When patients join a clinical trial, they make an informed decision in their healthcare by weighing all available options in addition to routine treatments. Research participants know that they are contributing meaningfully and helping other patients like them. Where can I find more information about clinical trials at Renown Health? Renown Health’s mission is to make a genuine difference in the health and well-being of the communities we serve. Renown’s clinical trial portfolio offers leading care options to patients in northern Nevada, close to home, in a variety of specialties. Contact the Renown Clinical Research Office for more information on clinical trials available to you!
Read More About What Does It Mean to Participate in a Clinical Trial?
-
How the UNR Med Affiliation Impacts Renown's Clinical Research
The University of Nevada, Reno School of Medicine (UNR Med) and Renown Health affiliated in June of 2021. First Integrated Health System The University of Nevada, Reno School of Medicine (UNR Med) and Renown Health affiliated in June of 2021. This agreement established Nevada’s first integrated health system with missions in education, patient care, and clinical research. While there was extensive media coverage regarding the historic partnership in general, there is less information regarding the important impact to the community. In terms of clinical research, the potential benefits are endless. The School of Medicine has a very successful program in molecular bio sciences. That means they have a plethora of brilliant minds working on the smallest components of life related to body systems and disease. With the affiliation, there is a distinct opportunity to bridge some of these important findings happening on campus and translate them into care protocols for the patients seen in the community. Making connections between the cellular basics to the physical manifestations of conditions is a key opportunity of the affiliation. Additionally, cooperative funding models for projects that fit in the translational research bucket are available to these researchers. Renown and UNR Med are poised to provide potentially cutting-edge treatments with bench to bedside research. Expanding Clinical Trials Perhaps the most important outcome of the affiliation is access to novel treatments via clinical trials. In the coming years, Renown and UNR Med will work to expand their clinical trial portfolio in an effort to provide a clinical trial option for many diseases in addition to standard of care. This endeavor will allow patients to make an informed choice about their healthcare. With novel treatments available right here in Reno, people won’t have to travel to other research institutions for similar care. This eases a tremendous potential burden on patients and families alike navigating complex illnesses like cancer. The affiliation is exciting and provides many opportunities for clinicians (present and future) and the community. Renown's Clinical Research Office is thrilled to be a part of this historic time and are enthusiastic to communicate our successes and opportunities to the community. We sincerely look forward to contributing to the vision of “a healthy Nevada.”
Read More About How the UNR Med Affiliation Impacts Renown's Clinical Research
-
A Renown Anesthesiologist's Unique Journey
Dr. Nariman Rahimzadeh’s career path has been anything but typical. From humble beginnings as a shuttle bus driver for Renown Regional Medical Center, then named Washoe Medical Center, to his service as Chief of Staff for Renown South Meadows Medical Center, the steps and detours he took along the way – and the strong support from his colleagues and family members – make up a tale of perseverance, conviction, compassion and inspiration. However, his healthcare career journey began several years before he even joined Washoe Medical Center in the 1990s. It all began 7,446 miles away in Iran. This is Dr. Rahimzadeh’s story. Defining Moments The moment Dr. Rahimzadeh knew he wanted to dedicate his career to the healthcare field started during his childhood. Growing up in Iran during the midst of the Iranian Revolution, a thought that often came to mind was, “Who is helping all the people injured in the war?” The answer? The doctors. “In Iranian society, doctors are extremely valued, as they are the first to help people in need,” said Dr. Rahimzadeh. “I knew I wanted to give back to society in some way, and I see my time in Iran as very formative in my future career. I just didn’t know it yet.” After immigrating to the U.S. with his family during his preteen years, he only had one mission: to support his family. “My desires were to help my family not fall behind,” he said. “I didn’t have career aspirations at the time. All I knew is that I wanted to help my family and my community, which immediately opened its arms up to us, as well as be a good student and a good ambassador for Iran.” Dr. Rahimzadeh remembers several influential people that helped solidify his aspiration from “helping people” to “helping people as a healthcare professional.” Their family physician and other medical professionals in the family’s lives were monumental in helping him make this decision. Coupled with his natural love for the sciences, the decision to become a doctor became clear. But the question remained, “How do I get started in the healthcare field?” No Links to Healthcare? No Problem With no physicians in his immediate family and no direct connections to healthcare, Dr. Rahimzadeh set off to follow the advice he received from the influential people in his life: get a job at a healthcare facility, regardless of what the job title is. Some of his friends had recently joined Washoe Medical Center as patient transporters and mentioned job openings that were available. He sprang into action and headed to Washoe Medical Center to apply. Just one problem – he didn’t have the EMT certification requirement. Enter Barry O’Sullivan, who would be Dr. Rahimzadeh’s first supervisor at Washoe Medical Center (and a friend he still speaks with to this day). Barry saw promise in Dr. Rahimzadeh immediately. As a result, Barry made a suggestion to him that would ultimately set him on the course towards medicine. “Barry told me that he had an open position that I could work while completing the senior year of my undergraduate degree and studying for my EMT certification and eventually becoming a patient transporter. He told me Washoe Medical Center would support me in this endeavor. So, I asked what the job was and learned it was driving a shuttle bus.” Without hesitation, Dr. Rahimzadeh responded, “I’ll take it.” And so, his fulfilling journey with Washoe Medical Center, and eventually Renown Health, began. While he finished up the last few months of his degree at the University of Nevada, Reno, (UNR) Dr. Rahimzadeh proudly drove the shuttle bus a few days a week. The job not only helped him pay for his degree and put food on the table, but it also allowed him to begin living out his passion for helping people in the healthcare field. Dr. Rahimzadeh graduated with his bachelor's degree in Pre-Medicine from UNR and finished his EMT certification program. Sure enough, Barry and Washoe Medical Center lived up to their promises and helped him secure his first direct healthcare job as an EMT and Patient Transporter with REMSA. But he didn’t stop there – after several years as a ground transporter, his career literally took flight. He joined REMSA Ground Ambulance and eventually Care Flight as a Flight EMT II, caring for patients that were flying to Washoe Medical Center from nearby communities that needed lifesaving medical care. Helping save lives every day as a member of the emergency medical team is an ultimate feat, especially when it comes to Dr. Rahimzadeh. And he didn’t stop there. Valuing One-on-One Connections In the 1990s, as it is today, the U.S. experienced a significant primary care provider shortage which resulted in many medical schools encouraging students to complete their residencies in a primary care specialty, like internal medicine – which is precisely what Dr. Rahimzadeh set out to do at the University of Connecticut. However, his mind would soon change about the course of his career. “I had a deep, introspective conversation with my residency program director, openly and honestly chatting about my future,” Dr. Rahimzadeh said. “I ended up taking a week off of my residency and wrote a long pros and cons list about what I wanted to do with my life in the medical field.” Eventually he decided on anesthesiology because of the opportunity to have a one-on-one relationship with every surgery patient, regardless of their procedure. “Even though it’s for a short duration of time, it is a very impactful relationship,” he said. “I feel I am making a difference in the outcomes and lives of patients every day.” Dr. Rahimzadeh finished his internal medicine residency in three years and passed his board exam, and he went on to do the same thing for anesthesiology. He then ventured back home to Reno. Career Progression at Its Finest Dr. Rahimzadeh knows that people don’t always get to settle down in a place that influenced their upbringing, care and dream, yet he was able to make that vision a reality for himself. “I feel like Renown Health and myself have this intertwined relationship that led to my growth as a person and as a physician,” he said. “For that, I feel very blessed." Upon his arrival back to Reno with two residencies under his belt, Dr. Rahimzadeh was quickly hired at one of the two anesthesiology groups in town at the time. He started his career with Sierra Anesthesia and after working for the group for several years, he joined Associated Anesthesiologists of Reno in 2014, which went on to become one of the largest anesthesiology groups in northern Nevada. The group continuously worked very closely with Renown, taking care of all of its surgical patient needs and eventually becoming Renown Medical Group employees as of April 1, 2022, with Dr. Rahimzadeh setting up his home base at the Renown South Meadows campus. Today, Dr. Rahimzadeh wears three “hats” at Renown. As a medical professional first and foremost, his largest “hat” is his general anesthesiologist role, where he cares for patients in the operating room. Another significant “hat” is his role as the Medical Director for Surgical Services, where he reviews surgical patient charges alongside his dedicated team of nurses and ensures optimal patient outcomes by verifying they have had the appropriate workup to proceed with surgery in a safe manner. To round out his immense responsibilities with Renown, he serves as Chief of Staff for Renown South Meadows, where he makes connections with colleagues and collaborates with leaders to review protocols, policies and address concerns that arise. Outside of Renown, Dr. Rahimzadeh is still a contributor within his own anesthesiology practice. He also is the current President of the Nevada State Society of Anesthesiologists and the Director to the Board of Directors of the American Society of Anesthesiologists, helping bridge the gap in anesthesia concerns between his northern and southern Nevada colleagues. He reflects on the opportunities Renown and our local community have extended to him by saying, “If you can dream big enough and continue to chase your dreams, you can make it happen right here.” On the COVID-19 Frontlines Nothing could prepare us for the dire situation hospitals on the east coast – especially those in Livingston, New Jersey – were experiencing at the beginning of the pandemic. Livingston was known as the “second hardest hit area” by COVID-19 in April of 2020. Hospitals were overwhelmed with patients in the ICU fighting for their lives. They needed help, and they needed help now. Unable and unwilling to sit idly by, Dr. Rahimzadeh and six of his colleagues from his practice traveled to Livingston to help. They jumped in on the frontlines alongside other anesthesiologists and intensivists to offset the sudden influx of COVID-19 patients. Many lives were saved, and Dr. Rahimzadeh was a direct part of that. “When you care and work with people that also care, you can move the needle a lot – it doesn’t matter where you're from,” he said. Home Means Nevada – and Renown Renown Health is deeply rooted in the northern Nevada community. Dr. Rahimzadeh is proud to be among a diverse team who have taken responsibility for its community for generations. "We live in a very passionate and caring community, which is often underestimated,” he said. “It’s clear to me that Renown refuses to settle. Renown is incredibly progressive in providing the best for the community. We never remain stagnant, we keep moving forward and we take care of your loved ones. This health system has never been able to sit still and settle for the status quo. That stands out to me.” One story especially sticks out to Dr. Rahimzadeh as the moment when he knew that Renown was home. In 1997 while working as a patient transporter, his grandmother passed away on the sixth floor of the Sierra Tower at what is now Renown Regional Medical Center. At the funeral, a huge bouquet of flowers arrived. Not being especially close to anyone in Reno yet, Dr. Rahimzadeh's family had no idea who sent the beautiful arrangement. Turns out, it was Rod Callahan, the Chief Operating Officer (COO) of Washoe Medical Center at the time. “At that point, I knew I wasn’t just a part of a workforce with thousands of employees,” said Dr. Rahimzadeh. “The COO cared so much about me that he felt compelled to send such a wonderful gift during a tragic time. That’s the value of a local, community-focused hospital; the people here know you and care about you. There’s a reason why people stay at Renown for so long – we feel that connection.” Dr. Rahimzadeh also reflected on how far Renown South Meadows has come, from the time he immigrated to the U.S. to today. “Growing up, Renown South Meadows was kind of a ‘mom and pop shop’ primarily serving senior citizens in one wing and surgical patients in the other,” he said. “Now, I am so proud to see how far it has come. It really made its niche in the community in a great way. The future is bright!” It’s clear that Dr. Rahimzadeh is leaving a lasting legacy with his family, from the local community to global medicine. His son is a senior at Baylor University in Texas with a strong desire to go into medicine, just like his dad. His daughter is a junior at Bishop Manogue Catholic High School in Reno and enjoys being involved in her community. His loving wife is a speech therapist in the area. The Rahimzadeh family is thriving together, and they all share the same conviction about northern Nevada and Renown: “This is home.”
-
Prestigious Honor Shines National Spotlight on Healthcare In Nevada
Renown Health President and CEO Dr. Tony Slonim recognized as one of Modern Healthcare’s 50 Most Influential Clinical Executives in the U.S. Renown Health President and CEO, Anthony Slonim, M.D., DrPH, FACHE, has been selected as one of the top influential clinical executives in the U.S. for his innovation and leadership in healthcare on a national level. Dr. Slonim is joined by an elite list of 50 esteemed honorees identified as Modern Healthcare’s “Most Influential Clinical Executives.” The list features leaders from top-rated institutions across the country including an impressive list of that includes Dr. Anthony Fauci, director, National Institute of Allergy & Infectious Diseases, Dr. Rochelle Walensky, director, Centers for Disease Control and Prevention, and colleagues from Weill Cornell Medicine, Yale School of Medicine, UCLA Health and more. Fawn Lopez, publisher and vice president of Modern Healthcare, the industry's leading source of healthcare business and policy news, research and information, noted, “Under Slonim’s leadership, Renown a couple of years ago launched the Healthy Nevada Project® with the goal of doing comprehensive population health work. The Project has sequenced genetic data with 60,000 study participants was expanded across the state. The system is also building a new clinically integrated network after joining forces with the University of Nevada School of Medicine. In 2018, Slonim was appointed by the governor as one of the two hospital officials on the state’s Patient Protection Commission, which advises policymakers on access and equity issues. During the pandemic, Renown was an early leader in adopting home monitoring systems, offering free ICU beds to those in need, and expanding disease monitoring. Slonim wrote passionately about the loss of his father to COVID and used that experience as the backdrop to advocate for more family and staff support structures.” “Under Dr. Slonim’s leadership, Renown Health is an extraordinary force for good in our community,” said James DeVolld, chair of the Renown Health Board and Managing Director, Commercial Banking at First Independent Bank. “He leads by example to serve our patients, employees and community, helping pave the way for other leaders and physicians to thrive at Renown. We are honored to serve our community alongside Tony as we work together to make a genuine difference for those we serve.” “We never would have anticipated the challenges we encountered through the pandemic. The highest priority of all CEOs - whether you are the leader of a state or a health system - is to ensure safety and the public’s health. Knowing I had a solid team in place to mitigate, prepare, respond, communicate, and recover from the COVID 19 outbreak and provide access to people who needed us most, gave me confidence and Dr. Slonim was a critical part of that team,” said Steve Sisolak, Governor of the State of Nevada. “Little did we know we would also face an economic crisis, political turmoil and significant social unrest. While at times these challenges seemed daunting, they also accelerated our ability to learn and grow together, to prove we could manage through times of great ambiguity, to move at unprecedented speeds, and have ultimately prepared us to change our world for the better. On reflection, it turned out that we could not have asked for better preparation for our future. Thank you, Dr. Slonim.” “Tony is just getting started! Renown Health and the University of Nevada, Reno School of Medicine (UNR Med) have announced our affiliation and the creation of the first integrated health system in northern Nevada, said Brian Sandoval, President, University of Nevada, Reno. “Dr. Slonim has always answered the call, and worked with me to improve health through proactive community-based prevention, to create an exceptional healthcare system for those with acute and chronic diseases, and to care for all people in our community. We are so fortunate to have him in Nevada.” During Dr. Slonim’s career at major healthcare organizations and academic institutions, he has developed a national profile as an academic leader and tenured professor, holding appointments as clinical professor in the departments of internal medicine and pediatrics at the University of Nevada, Reno School of Medicine. Dr. Slonim is also an expert in patient safety, accountable care, health care quality and innovative care delivery models focused on improving health within the community. Since joining Renown as CEO and President in July 2014, Dr. Slonim has completely reoriented northern Nevada’s largest locally governed, not-for-profit healthcare network. With a personal passion for population health, Dr. Slonim created the Institute for Healthcare Innovation, launching the nation’s first community-based, population health study that currently has more than 60,000 participants and is returning clinical results on the first three genetic conditions identified. The Healthy Nevada Project® is a collaboration with global leader in environmental data, Desert Research Institute, and personal genomics company, Helix. The Healthy Nevada Project combines genetic, environmental, social and clinical data to address individual and community health needs with the goal of improving health across the state, and the nation. The “50 Most Influential Clinical Executives” awards and recognition program honors individuals in healthcare deemed by their peers and the senior editors of Modern Healthcare to be paving the way to better health through their executive responsibility, leadership qualities, community service and achievements inside and outside of their organization. Judging for the final ranking of the 50 Most Influential list is based on readers’ votes as well as input from the senior editors of Modern Healthcare. Dr. Slonim was among the initial nominee list of 150 names published in March 2021. For more information about the program, please contact Jodi Sniegocki. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Clinical institutes include: Cancer, Heart and Vascular Heath, Neurosciences and Robotic Surgery. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information, visit renown.org.
Read More About Prestigious Honor Shines National Spotlight on Healthcare In Nevada
-
Renown Health Welcomes New Chief Information Technology Officer
Chuck Podesta, national IT leader to use technology to improve the health and well-being of Nevadans. Renown Health is pleased to announce Charles (Chuck) Podesta has been named Chief Information Officer. Podesta is a seasoned executive with over 30 years of experience leading some of the nation’s top healthcare IT teams. He has literally worked from coast to coast and is excited to bring his talents to Nevada. “We are pleased to bring an experienced and talented leader like Chuck Podesta to lead our information and technology areas at Renown,” said Tony Slonim, MD, DrPH, President & CEO of Renown. “As Chief Information Officer, he will have the opportunity to foster a culture of innovation and excellence in information technology which serves hundreds of thousands of people across the state and the nation. Chuck will use the power of technology to bring a new level of convenience to patients and providers and will use his talents and team to improve the health and well-being of Nevadans.” Chuck most recently served as Interim Chief Information Officer for UCONN Health’s John Dempsey Medical Center, School of Medicine and Clinical Research IT. Prior to that, Chuck served as CIO for UCI Health/UC Irvine School of Medicine and the University of California Health System. He also served as CIO for University of Vermont Health Network/Fletcher Allen Health; Steward Health/Caritas Christi Healthcare; Berkshire Health; Baystate Health and UMASS Medical Center, all in the New England area. Podesta specializes in creating, resourcing and implementing strategic technology plans; maximizing the power of the Epic electronic medical record; streamlining governance and priorities; aligning IT and medical informatics needs across affiliated entities including a medical school environment, Accountable Care Organizations (ACOs), Clinically Integrated Networks (CINs) and medical practices; partners to implement best of breed customer-driven digital tools; leads participation in state-wide health exchanges (HIE) and coaches and mentors IT teams. “Chuck’s experience and strengths in a variety of diverse and complex environments make him the perfect leader for us at this important time in our history,” explains Josiah (Sy) Johnson, Chief of Staff for Renown. Chuck will assure we are leading with innovative and contemporary approaches and integrating technology and expertise in our ongoing pursuit of excellence in improving health and healthcare in Nevada. “I am honored and excited to join the Renown Health family and the northern Nevada community,” says Chuck Podesta, Chief Information Officer. “I am impressed with the innovation and transformation at Renown; which has earned it a reputation as one of the nation’s leading health systems. I look forward to joining Renown Health at this exciting time in its history. I am excited to bring my skills and experience to create a positive experience when people use our technology. I am looking forward to leading the organization on this important journey.” Podesta is a graduate of the Massachusetts College of Liberal Arts and an active member of CHIME, HIMSS and the Society for Information Management (SIM). Podesta will begin at Renown on July 12. About Renown Health Renown Health is the region’s largest, local not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,200 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Clinical institutes include: Cancer, Heart and Vascular Heath and Neurosciences. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information, visit renown.org.
Read More About Renown Health Welcomes New Chief Information Technology Officer
-
Prestigious Honor Shines National Spotlight on Health Care in Nevada
Renown Health CEO, Dr. Tony Slonim Elected to Highest Office with American Hospital Association. Renown Health President and CEO, Anthony Slonim, M.D., DrPH, FACHE, has been elected to serve as a member of the American Hospital Association (AHA) Board of Trustees for a three-year term beginning Jan. 1, 2022. The Board of Trustees is the highest policymaking body of the AHA and has ultimate authority for the governance and management of the organization. The American Hospital Association (AHA) is the national organization that represents over 40,000 individual members and serves over 5,000 hospitals, health care networks, and their patients and communities. As a representative and advocate for those serving in the health care field, Dr. Slonim's role as a Trustee will be to ensure that members' perspectives and needs are heard and addressed in national health policy development, legislative and regulatory debates, and judicial matters. Dr. Slonim joins an elite list of CEOs from the nation’s most respected health care organizations in AHA Board service, including Yale New Haven Health (CT), Dartmouth Hitchcock Health (NH), Providence Health (WA), Henry Ford Health (MI), UMass Memorial Health (MA), Vanderbilt University Medical Center (TN), and Advocate Aurora Health (WI). The American Hospital Association was founded in 1898, the same year Marie Curie began studying uranium as a treatment for cancer. Dr. Slonim is among the first health care leaders from Nevada elected to serve on the AHA Board of Trustees. In an announcement to the national media, the AHA wrote, “Anthony Slonim, MD, DrPH, leads Renown's charitable mission of making a genuine difference in the community's health and well-being for one of the nation's most innovative and progressive health systems.” Steve Sisolak, Governor of the State of Nevada, in support of Dr. Slonim’s nomination wrote, “Both Dr. Slonim and I share a common interest for improving the health of over 3 million residents of our state. I urge you to appoint him to this position, as his national leadership would benefit the American Hospital Association, our state and our nation.” Brian Sandoval, President of the University of Nevada wrote in his nomination, “Dr. Slonim has always answered the call, and worked with me to improve health through proactive community-based prevention, to create an exceptional healthcare system for those with acute and chronic diseases, and to care for all people in our community.” Bill Welch, President and CEO of the Nevada Hospital Association, wrote in support, “I consider Dr. Anthony Slonim to be one of the most extraordinary leaders in health care today.” Dr. Slonim is recognized nationally as a thought and opinion leader who does not accept the status quo. He is a quadruple board-certified physician by training and holds a Doctorate in Public Health and Health Policy with Fellowships in the American College of Healthcare Executives (ACHE), American Association of Physician Leaders (AAPL), and the College of Critical Care Medicine. Dr. Slonim’s holds a university appointment at the University of Nevada, Reno School of Medicine, is a highly sought after speaker on healthcare trends and leadership development, holds a Six Sigma Black Belt and is a 2-time TEDx speaker. Dr. Slonim has authored more than 120 publications, 15 textbooks, and has millions of dollars in research funding to his name. Modern Healthcare has named Dr. Slonim as one of the 50 Most Influential Leaders in Healthcare. He has been named to Becker's Hospital Review's "Physician Leaders to Know" list since 2014. Before joining Renown Health in 2014, Slonim served on the senior leadership teams for Barnabas Health in New Jersey, Carilion Clinic in Virginia and Children's National Medical Center in Washington, D.C. Slonim, who was also a registered nurse, got his medical degree from New York Medical College, served four years in the U.S. Public Service Commissioned Corps as a commander, and earned both his master's and doctoral degrees in public health and health policy from The George Washington University's Center for Health Policy Studies. About Renown Health Renown Health is a locally governed, not-for-profit integrated healthcare network serving northern Nevada, Lake Tahoe and northeast California. Renown has a long tradition and commitment to improving the care and the health of our community. For more information, visit renown.org.
Read More About Prestigious Honor Shines National Spotlight on Health Care in Nevada
-
Renown Welcomes New Chief Clinical and Quality Officer; Thomas Graf, MD
Dr. Graf will support clinical providers in delivering the most effective, highest-quality patient care at lowest cost. Renown Health is excited to announce that Dr. Thomas Graf is joining the organization as its Chief Clinical and Quality Officer on September 20. In this role, Dr. Graf will support clinicians in delivering the most effective, highest-quality patient care at the lowest cost. Dr. Graf will also assist Renown in expanding innovative care models like Hospital at Home and remote patient monitoring technology to deliver patient-centered health care that both convenient and affordable. “At Renown, delivering the highest quality care is our #1 priority. Embracing our vision to improve the health of our community, we are pleased to welcome an experienced leader like Dr. Graf to our organization and to Nevada,” said Tony Slonim, MD, D.Ph., President and CEO, Renown Health. “As the Chief Clinical and Quality Officer, Tom will fuel Renown’s transformation to a value-based care organization, help advance technologies to enhance the patient experience, and collaborate with providers in our medical group, acute care hospitals, and through our clinically integrated network, accountable care organization and affiliation with UNR Med to create a healthier Nevada. Dr. Graf embodies our core values of caring, integrity, collaboration and excellence, and respect for all. We are thrilled to bring him to the Silver State, and to continue to offer health care that is affordable, accessible and of the highest quality.” Graf is a highly accomplished physician executive with leadership experience from leading health care and insurance organizations as well as a national consulting firm. A family medicine physician, researcher and academic, Dr. Graf has focused on driving quality improvement to lower the total cost of care. He has developed and published on care models that have delivered measurably better results for quality, cost, and experience in a variety of venues. He has practiced in an integrated delivery system, with over a decade at Geisinger (PA), as well as clinically integrated networks and accountable care organizations. He also has worked with a number of academic medical centers through his consulting work with The Chartis Group. Dr. Graf is respected for his adaptable and effective leadership style and the ability to create consensus through shared perspectives. Dr. Graf adds, “My goal is to produce greater value for the patient by delivering care that is of highest clinical quality. Renown has a national reputation for delivering excellent care using approaches that are creative, innovative and maximize technology, and I look forward to engaging physicians and administrators in an agenda that supports this vision.” Dr. Graf comes to Renown from Ascension in St. Louis, MO, where he served as Senior Vice President, Chief Population Health and Value Based Care Officer. He has extensive experience in population health, having been involved in clinical re-engineering and payment model evolution since 2005 with the Centers for Medicare & Medicaid Services in the Physician Group Practice Demonstration project as well as Geisinger’s Proven Care® and ProvenHealth Navigator® programs. “Choosing a physician and hospital for their care is one of the most important decisions people will ever make. I am excited to begin my work with Renown to help patients enhance their health and well-being,” said Dr. Graf. “I am grateful for the opportunity to contribute to the great progress that Renown Health is making in becoming the best place to practice medicine and to receive care. I am excited to join this journey of transformation to value- based care, and to serve patients, clinicians and the community.” Dr. Graf will report directly to Dr. Tony Slonim, president and CEO, Renown Health. Dr. Graf earned his Doctor of Medicine from University of Michigan, Ann Arbor, and completed his Family Practice Residency at Henry Ford Health System in Detroit. In U.S. News and World Report Best Hospital Rankings, Renown Regional Medical Center is named #1 in the State of Nevada for 2021. No other hospital in Nevada earned recognition from U.S. News. About Renown Health Renown Health is a locally governed, not-for-profit integrated healthcare network serving northern Nevada, Lake Tahoe and northeast California. Renown is one of the region's largest private employers with a workforce of more than 7,000. It comprises three acute care hospitals, the region's only children's hospital, a rehabilitation hospital, the area's most comprehensive medical group and urgent care network, and the region's largest and only locally owned not-for-profit insurance company, Hometown Health. Renown has a long tradition and commitment to improve the care and the health of our community. For more information, visit renown.org.
Read More About Renown Welcomes New Chief Clinical and Quality Officer; Thomas Graf, MD
-
Renown Welcomes Director, Cardiovascular Services; Jayson Morgan, MD, FACC
Dr. Morgan embraces a patient-centered approach to delivering a comprehensive cardiac and vascular program in Nevada. Renown Health is excited to announce that Dr. Jayson Morgan has been promoted to serve as Director of the Cardiovascular Services. Dr. Morgan, who formerly served as the Cardiology Division Chief, began his new position on September 6. Dr. Morgan plays a key role in supporting clinical and administrative leaders to embrace a patient-centered approach in delivering the most effective, highest-quality care within the Institute for Heart and Vascular Health and across Renown Health. Dr. Morgan will expand care, enhance clinical outcomes and transform cardiovascular health care through adopting technological advances which promote patient-centered health care that is both convenient and affordable. “At Renown, delivering the highest quality care is our #1 priority. Embracing our vision to improve the health of Nevadans, we are pleased to promote an extraordinary physician like Dr. Morgan to lead and further develop cardiovascular services - and elevate and grow this important Destination Health program to serve the growing needs of our community,” said Tony Slonim, MD, D.Ph., President and CEO, Renown Health. “Unfortunately, Heart Disease continues to be the #1 cause of death in Washoe County, the state and the nation. Dr. Morgan and his team focus on saving lives and reducing the number of people needing heart and vascular interventions. He embodies our core values of caring, integrity, collaboration and excellence, and respect for all, and we are pleased to have Dr. Morgan at the helm of our cardiovascular program.” Dr. Jayson Morgan is a highly accomplished physician leader. He served as both an Internal Medicine Hospitalist and an Internal Medicine resident at UCSF Health in San Francisco, where he specialized in the care of advanced heart failure, pulmonary hypertension, and heart transplant patients. He completed his cardiology fellowship at Cedars-Sinai Medical Center in Beverly Hills, CA in 2017 and immediately joined Renown afterwards. In 2019, he served as director of the Echocardiography laboratory at Renown. In 2020, he was promoted to Division Chief, Cardiology. “The experts at Renown’s Institute for Heart and Vascular Health provide an integrated, multi-disciplinary, patient-centered approach to the prevention, diagnosis and treatment of heart and vascular disease. I am proud to have Dr. Jayson Morgan leading a team of experts who respond to and treat heart and vascular problems that extend from mild to the most critical of emergencies. Our specialized physicians (cardiologists, interventional radiologists, heart and vascular surgeons) work collaboratively with our clinical team to determine the best treatment plan for each patient,” says Rahul Mediwala, MD, Medical Director, Health Services. “High blood pressure, heart disease, and stroke affect one in three Nevada residents. These diseases are preventable and many acute events are avoidable, by leading heart-healthy lifestyles including not using tobacco products, limiting sodium and adopting a plant-based diet, engaging in at least 30 minutes of physical activity daily, limiting or eliminating alcohol consumption, and following prescribed medication regimens. Together, we can make a genuine difference in improving the health of our families, friends and neighbors,” says Jayson Morgan, MD, FACC, Director, Cardiovascular Services. “We are pleased to offer a medically supervised, Pritikin-certified, intensive cardiac rehabilitation (ICR) program for those with heart disease. Our expert team creates tailored plans, providing the support heart patients need to make lasting lifestyle changes.” Dr. Morgan continues, “Renown now has 3 cardiac surgeons, 17 cardiologists and 16 advanced practice providers who provide excellent cardiovascular care. Our technical capabilities have expanded with a structural heart program including trans catheter aortic valve replacements (TAVR), trans catheter mitral valve repairs (Mitraclip), patent foramen ovale closures, and atrial septal-defect closures; with over 100 structural heart procedures being performed each year. Our Cardiothoracic surgeons are the highest volume in the region and consistently exceed national performance standards for operative care. Renown Regional Medical Center was the first hospital in the region to implant the CardioMEMS pulmonary artery pressure monitoring system for advanced heart failure patients, dramatically reducing hospitalizations in these patients. Three interventional cardiologists have joined our team which has expanded our capacity to handle interventions for complex coronary artery disease. Renown’s three electrophysiologists have performed over 1000 procedures this year, drastically decreasing the symptomatic burden of atrial fibrillation in our community. In addition, with the UNR Medical School affiliation, we look forward to even greater contributions to cardiovascular research.” Dr. Morgan graduated from Stanford University School of Medicine and graduated from Yale University with his undergraduate education in Chemical Engineering. “I am excited to continue to help patients enhance their health and well-being,” said Dr. Morgan. “I am grateful for the opportunity to contribute to the great progress that Renown Health is making in becoming the best place to practice medicine and to receive care. I am excited to advance our journey of transformation to value-based care, and to serve patients, clinicians and the community.” To make an appointment with a provider at Renown’s Institute for Heart and Vascular Health, request that your primary care provider make a referral. For more information on Renown’s Institute for Heart and Vascular Health, visit renown.org/Health-Services/Heart-Care. Renown Institute for Health and Vascular Health is the recipient of a number of national awards for outstanding clinical care and service, including: In U.S. News and World Report Best Hospital rankings for 2021, Renown Regional Medical Center- #1 in the State of Nevada for 2021. No other hospital in Nevada earned recognition from U.S. News. Renown Regional Medical Center is High Performing, its highest rating possible, for Heart Failure and Chronic Obstructive Pulmonary Disease. Awarded by the American College of Surgeons for the Renown Regional earned America’s 100 Best Hospitals for Critical Care Award™ (2021) for Superior clinical outcomes in treating pulmonary embolism, respiratory system failure, sepsis, and diabetic emergencies. Regional also earned the Pulmonary Care Excellence Award (2021), for superior outcomes. Designated Level II Trauma Center. For the 30th year, Renown Regional Medical Center is northern Nevada's only designated level II trauma center. Renown Regional awarded The Get with the Guidelines – Heart Failure Gold Plus Quality Achievement award for continually ensuring heart failure patients receive the most appropriate treatment according to nationally recognized, research-based guidelines, as well as AHA’s Mission: Lifeline Gold Receiving honor for the treatment of patients who suffer severe heart attacks. American College of Cardiology’s NCDR Chest Pain ̶ MI Registry Platinum Performance Achievement Award. Renown Regional Medical Center is one of only 225 hospitals nationwide to receive the honor. The award recognizes Renown’s success in implementing a higher standard of care for heart attack patients and signifies that Renown has reached an aggressive goal of treating these patients to standard levels of care as outlined by the American College of Cardiology/American Heart Association clinical guidelines and recommendations. About Renown Health Renown Health is a locally governed, not-for-profit integrated healthcare network serving northern Nevada, Lake Tahoe and northeast California. Renown is one of the region’s largest private employers with a workforce of more than 7,000. It comprises three acute care hospitals, the region’s only children’s hospital, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown has a long tradition and commitment to improve the care and the health of our community. For more information, visit renown.org.
Read More About Renown Welcomes Director, Cardiovascular Services; Jayson Morgan, MD, FACC
-
Study Shows Importance of Ensuring Participant and Provider Follow-up After a Genetic Screening Result
Released in partnership with the Desert Research Institute: New research from the Healthy Nevada Project® finds that a confirmed diagnosis does not always result in changes to patient care. Presenting individuals with potentially life-altering health information doesn’t mean the individuals – or their healthcare providers – will act on it. Follow-up education and conversations about actionable care plans with patients and their doctors are key next steps, according to new research from the Healthy Nevada Project. The Healthy Nevada Project is a genetic screening and research project that launched in 2016 as a partnership between DRI and Renown Health. The project now has more than 50,000 participants, with genetic sequencing provided by Helix. Between September 2018 and September 2020, the Healthy Nevada Project successfully notified 293 participants that they were genetically at risk for hereditary breast and ovarian cancer syndrome, Lynch syndrome, or familial hypercholesterolemia – three common genetic conditions known collectively as the Centers for Disease Control and Prevention (CDC) Tier 1 conditions. In a study published today in Frontiers in Genetics, Healthy Nevada Project scientists looked at the impact that notifying a patient of a positive finding for a CDC Tier 1 condition had on the care that the patient received in the months and years that followed. According to their results, among the 293 Healthy Nevada Project participants who were notified of their genetic risk of a CDC Tier 1 condition, 71 percent of participants with electronic health records shared their findings with healthcare providers. However, only 30 percent of the electronic health records for these patients contained documentation of the genetic diagnosis, and only 10 percent of examined patients experienced a possible change in care after receiving the results of their genetic screening. “The Healthy Nevada Project was implemented with a ‘hands-off’ approach where the participants receive their findings and decide with whom and when to share those findings. The findings were not automatically added to their electronic health records,” said Dr. Gai Elhanan, health data scientist at DRI and co-lead author of the study. “What we’re learning now is that to ensure that important genetic findings are integrated into the care journey it is important to make their inclusion into the electronic health records part of the study.” This study builds on previous Healthy Nevada Project research published in Nature Medicine demonstrating the importance of screening for CDC Tier 1 conditions, which affect about one in 75 individuals and can be mitigated or even prevented from developing into disease when detected early. This study found that as many as 90 percent of the CDC Tier 1 cases are missed by clinical providers during normal clinical care screenings and examinations. During the current study, the Healthy Nevada Project scientists found that 19 percent of studied participants had already developed one of the CDC Tier 1 conditions, and thus would have potentially benefited from earlier notification about their condition. The study team hopes that their findings will encourage individuals in Nevada to obtain genetic testing for these relatively common conditions. Even if individuals are older or have already suffered from diseases related to these conditions, testing could also prove beneficial to siblings, children, and grandchildren who may also be at risk and who could subsequently be screened in the event of a positive finding. The study team also encourages informing health care providers of the importance of incorporating genetic diagnoses into the pharmaceutical (for example, for Familial Hypercholesterolemia) and treatment advice given to patients. “As a result of this analysis, the clinicians at Renown Health and the Healthy Nevada Project researchers have made significant changes, including obtaining informed consent from participants to report positive findings from their genetics reports directly into their electronic medical record,” said Daniel Kiser, M.S., assistant research scientist of data science at DRI and co-lead author of the study. “This will help both participants, their clinical providers, and the whole state maximize the long-term benefits of the Healthy Nevada Project voluntary population-based genetic screening.” Additional information: The full text of the study, Incomplete Penetrance of Population-Based Genetic Screening Results in Electronic Health Record, is available from Frontiers in Genetics: https://www.frontiersin.org/articles/10.3389/fgene.2022.866169/full?&utm_source=Email_to_authors_&utm_medium=Email&utm_content=T1_11.5e1_author&utm_campaign=Email_publication&field=&journalName=Frontiers_in_Genetics&id=866169. This project was funded by Renown Health, the Renown Health Foundation, and the Nevada Governor’s Office of Economic Development. Study authors included Gai Elhanan (DRI), Daniel Kiser (DRI), Iva Neveux (DRI), Shaun Dabe (Renown Health), Alexander Bolze (Helix), William Metcalf (DRI), James Lu (Helix), and Joseph Grzymski (DRI/Renown Health). For more information on the Healthy Nevada Project® or to request genetic screening, please visit: https://healthynv.org/ About DRI The Desert Research Institute (DRI) is a recognized world leader in basic and applied environmental research. Committed to scientific excellence and integrity, DRI faculty, students who work alongside them, and staff have developed scientific knowledge and innovative technologies in research projects around the globe. Since 1959, DRI’s research has advanced scientific knowledge on topics ranging from humans’ impact on the environment to the environment’s impact on humans. DRI’s impactful science and inspiring solutions support Nevada’s diverse economy, provide science-based educational opportunities, and inform policymakers, business leaders, and community members. With campuses in Las Vegas and Reno, DRI serves as the non-profit research arm of the Nevada System of Higher Education. For more information, please visit www.dri.edu. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information, visit renown.org. About Helix Helix is the leading population genomics and viral surveillance company operating at the intersection of clinical care, research, and data analytics. Helix enables health systems, life sciences companies, payers, and government partners to accelerate the integration of genomic data into patient care and public health decision making. Learn more at www.helix.com.